Skip to main content
Edwards Lifesciences Corp logo

Edwards Lifesciences Corp — Investor Relations & Filings

Ticker · EW ISIN · US28176E1082 LEI · YA13X31F3V31L8TMPR58 US Manufacturing
Open in API
Filings indexed 1,951 across all filing types
Latest filing 2026-05-27 Regulatory Filings
Country US United States of America
Listing US EW

About Edwards Lifesciences Corp

https://www.edwards.com

Edwards Lifesciences is a medical technology company specializing in patient-focused innovations for structural heart disease. The company designs, develops, and manufactures a portfolio of technologies for treating advanced cardiovascular conditions. Its core product areas include transcatheter heart valve therapies for aortic, mitral, and tricuspid diseases, as well as surgical heart valve technologies and advanced tissue solutions. Through extensive clinical research and collaboration with healthcare professionals, Edwards Lifesciences is dedicated to advancing the standard of care and providing transformative solutions for patients worldwide.

Recent filings

Filing Released Lang Actions
SD
Regulatory Filings Classification · 95% confidence The document is an SEC Form SD (Specialized Disclosure Report) covering conflict minerals disclosure for the period Jan 1–Dec 31, 2024. It is a regulatory compliance filing rather than a full Annual Report, Interim Report, or any other specialized category. It primarily attaches or references a Conflict Minerals Report as an exhibit, making it a standard regulatory disclosure. Therefore, it falls under the fallback category “Regulatory Filings” (RNS).
2026-05-27 English
8-K - Edwards Lifesciences Corp (0001099800) (Filer)
Declaration of Voting Results & Voting Rights Announcements Classification · 85% confidence The document is a Form 8-K current report containing, among other items, the final results of stockholder votes at the company’s Annual Meeting (Item 5.07). It provides detailed voting tallies for director elections and other proposals, matching the definition of “Declaration of Voting Results & Voting Rights Announcements” (DVA).
2026-05-08 English
8-K - Edwards Lifesciences Corp (0001099800) (Filer)
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated April 23, 2026, by Edwards Lifesciences Corporation. It specifically references Item 2.02 "Results of Operations and Financial Condition" and includes a press release reporting the company's financial results for the first quarter of 2026. The document states that the press release is furnished as an exhibit and incorporated by reference, and the text itself does not contain detailed financial statements or substantive financial data but rather announces the release of the earnings information. The document length is 3580 characters, which is relatively short and consistent with an announcement rather than a full earnings report. According to the rules, such a document is classified as an Earnings Release (ER) because it is the initial announcement of quarterly financial results with key highlights only, not a full interim report or annual report. Therefore, the appropriate classification is ER with high confidence.
2026-04-23 English
SCHEDULE 13G/A - Edwards Lifesciences Corp (0001099800) (Subject)
Major Shareholding Notification
2026-03-26 English
4 - EDWARDS LIFESCIENCES CORP (0001099800) (Filer)
Director's Dealing
2026-03-02 English
4 - EDWARDS LIFESCIENCES CORP (0001099800) (Filer)
Director's Dealing
2026-02-27 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.